Transgene (France) Today

TNG Stock  EUR 1.11  0.02  1.77%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Over 87

 
100  
 
Zero
Very High
Transgene is trading at 1.11 as of the 28th of March 2024, a -1.77 percent decrease since the beginning of the trading day. The stock's open price was 1.13. Transgene has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Transgene SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Transgene SA, a biotechnology company, designs, develops, and produces therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. The company was founded in 1979 and is headquartered in Illkirch-Graffenstaden, France. The company has 100.2 M outstanding shares. More on Transgene SA

Moving together with Transgene Stock

  0.9VLA ValnevaPairCorr
  0.86DBV DBV TechnologiesPairCorr
  0.81IPH Innate PharmaPairCorr

Moving against Transgene Stock

  0.9MLCFD Compagnie De CheminsPairCorr
  0.87ABVX Abivax SA Earnings Call This WeekPairCorr
  0.83MEDCL Medincell SAPairCorr
  0.76ALCOF Cofidur SAPairCorr
  0.63VIV Vivendi SAPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Transgene Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Transgene's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Transgene or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
Transgene SA (TNG) is traded on Euronext Paris in France and employs 143 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 205.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Transgene's market, we take the total number of its shares issued and multiply it by Transgene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Transgene SA operates under Healthcare sector and is part of Biotechnology industry. The entity has 100.2 M outstanding shares. Transgene SA has accumulated about 16.9 M in cash with (31.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27.
Check Transgene Probability Of Bankruptcy
Ownership Allocation
Transgene maintains a total of 100.2 Million outstanding shares. About 98.0 % of Transgene outstanding shares are held by general public with 1.7 % by institutional holders. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Transgene Ownership Details

Transgene Stock Price Odds Analysis

What are Transgene's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Transgene jumping above the current price in 90 days from now is about 84.13%. The Transgene SA probability density function shows the probability of Transgene stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Transgene SA has a beta of -0.1986. This usually implies as returns on benchmark increase, returns on holding Transgene are expected to decrease at a much lower rate. During the bear market, however, Transgene SA is likely to outperform the market. Additionally, transgene SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 1.11HorizonTargetOdds Above 1.11
15.77%90 days
 1.11 
84.13%
Based on a normal probability distribution, the odds of Transgene to move above the current price in 90 days from now is about 84.13 (This Transgene SA probability density function shows the probability of Transgene Stock to fall within a particular range of prices over 90 days) .

Transgene SA Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Transgene market risk premium is the additional return an investor will receive from holding Transgene long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Transgene. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Transgene's alpha and beta are two of the key measurements used to evaluate Transgene's performance over the market, the standard measures of volatility play an important role as well.

Transgene Stock Against Markets

Picking the right benchmark for Transgene stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Transgene stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Transgene is critical whether you are bullish or bearish towards Transgene SA at a given time. Please also check how Transgene's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Transgene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Transgene Corporate Management

Elected by the shareholders, the Transgene's board of directors comprises two types of representatives: Transgene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Transgene. The board's role is to monitor Transgene's management team and ensure that shareholders' interests are well served. Transgene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Transgene's outside directors are responsible for providing unbiased perspectives on the board's policies.

How to buy Transgene Stock?

Before investing in Transgene, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Transgene. To buy Transgene stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Transgene. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Transgene stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Transgene SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Transgene SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Transgene SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Transgene SA?

The danger of trading Transgene SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Transgene is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Transgene. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Transgene SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Transgene SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Note that the Transgene SA information on this page should be used as a complementary analysis to other Transgene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Transgene Stock analysis

When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Please note, there is a significant difference between Transgene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Transgene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Transgene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.